{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-173591","form_type":"8-K","ticker":"VERA","cik":"0001831828","company_name":"Vera Therapeutics, Inc.","filed_at":"2025-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.207015+00:00","generated_at":"2026-05-17T20:58:26.544057+00:00","sec_items":["1.01","1.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Vera Therapeutics enters $200M at-the-market equity offering agreement with TD Cowen","bullets":["New Sales Agreement with TD Cowen to sell up to $200M of Class A common stock from time to time.","Prior $200M ATM agreement with TD Cowen terminated effective August 5, 2025.","TD Cowen will receive up to 3.0% commission on gross proceeds of shares sold.","Company not obligated to sell any shares; sales subject to company instructions and market conditions.","Issuance will be made under existing S-3 shelf registration statement."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-173591","json":"https://secwatch.observer/filing/0001193125-25-173591.json","markdown":"https://secwatch.observer/filing/0001193125-25-173591.md","text":"https://secwatch.observer/filing/0001193125-25-173591.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831828/000119312525173591/0001193125-25-173591-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831828/000119312525173591/d42398d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T20:58:26.544057+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}